Fredun Pharmaceuticals Ltd. - Research Center
539730 FREDUN Group (X) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
118.03 |
86.65 |
81.48 |
61.23 |
79.73 |
Operating profit |
11.17 |
10.16 |
9.10 |
6.79 |
12.18 |
Interest |
4.37 |
3.77 |
2.90 |
2.61 |
3.55 |
Gross profit |
6.79 |
6.75 |
6.71 |
5.00 |
8.71 |
EPS (Rs) |
10.77 |
8.99 |
8.40 |
5.24 |
8.59 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
- |
0.35 |
0.50 |
0.82 |
0.08 |
Stock adjustment |
-1.90 |
-12.06 |
-19.26 |
10.78 |
-13.29 |
Raw material |
91.82 |
75.56 |
81.67 |
34.44 |
67.82 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
3.90 |
2.97 |
2.93 |
2.69 |
3.94 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
13.05 |
10.02 |
7.03 |
6.53 |
9.07 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.96 |
0.99 |
0.94 |
0.92 |
0.70 |
Taxation |
0.78 |
1.54 |
1.83 |
1.68 |
4.12 |
Net profit / loss |
5.06 |
4.22 |
3.94 |
2.40 |
3.89 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
4.70 |
4.70 |
4.68 |
4.58 |
4.53 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
9.46 |
11.73 |
11.17 |
11.09 |
15.28 |
GPM (%) |
- |
7.76 |
8.18 |
8.05 |
10.91 |
NPM (%) |
- |
4.85 |
4.80 |
3.87 |
4.88 |